Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

24

Mar 2026

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.

Excessive screen time linked to worse cardiovascular risk factors

24

Mar 2026

Excessive screen time linked to worse cardiovascular risk factors

People who reported spending six or more hours on screens outside of school or work had worse blood pressure, cholesterol and body mass index (BMI) compared with those with more limited screen time, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

Medicare reforms improve medication adherence among older adults with heart disease

24

Mar 2026

Medicare reforms improve medication adherence among older adults with heart disease

Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication non-adherence-skipping or reducing doses, delaying prescription fills or foregoing medications due to cost-after new provisions went into effect limiting out-of-pocket drug costs for Medicare beneficiaries, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.26) and simultaneously published in JACC, the flagship journal of the ACC.

Transportation noise linked to higher risk of major cardiac events

24

Mar 2026

Transportation noise linked to higher risk of major cardiac events

Living in areas with consistently higher levels of noise from transportation was associated with a significantly higher risk of major adverse cardiac events compared with living in quieter areas, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

Extreme cold linked to sharp rise in heart-related deaths

24

Mar 2026

Extreme cold linked to sharp rise in heart-related deaths

On the heels of one of the coldest winters in memory for large swaths of the country, new research highlights an often overlooked cost of cold weather: months with lower temperatures see significantly greater rates of death from heart attacks, strokes and coronary artery disease than milder months.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.